Autolus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Autolus Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.31 | $-0.21 | -47.6 % |
Q2 | 2024-08-08 | $-0.22 | $-0.19 | -15.8 % |
Q1 | 2024-05-16 | $-0.24 | $-0.05 | -380.0 % |
Q4 | 2024-03-14 | $-0.45 | $-0.25 | -80.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $0 | $130.00K | -100.0 % |
Q2 | 2024-08-08 | $0 | $60.00K | -100.0 % |
Q1 | 2024-05-16 | $10.09M | $25.00M | -59.6 % |
Q3 | 2023-11-02 | $406.00K | $450.00K | -9.78 % |
Autolus Therapeutics (AUTL) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.31, which missed the estimate of $-0.21.
The Actual Revenue was $0K, which missed the estimate of $130K.
Browse earnings estimates, EPS, and revenue on all stocks.